Evidence map›Paper›PMID 40786649›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2025

[Distribution of the COVID-19 vaccine: experience in EcuadorOperacionalização da vacinação contra a COVID‑19: experiência no Equador].

José Ruales, Ximena Garzón, Cristina Aldaz, Nancy Vásconez, Fernando Jácome, Jacqueline Cevallos, Jackeline Pinos, Francisco Pérez-Tasigchana, Adrián Díaz, Alvaro Whittembury

Abstract readEnglish Abstract
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

José RualesFacultad de Ciencias de la Salud Universidad Internacional SEK Quito Ecuador Facultad de Ciencias de la Salud, Universidad Internacional SEK, Quito. Ecuador.
Ximena GarzónUniversidad San Francisco de Quito Quito Ecuador Universidad San Francisco de Quito, Quito. Ecuador.
Cristina AldazUniversidad Internacional del Ecuador Quito Ecuador Universidad Internacional del Ecuador, Quito. Ecuador.
Nancy VásconezConsultora independiente Ecuador Consultora independiente. Ecuador.
Fernando JácomeOrganización Japonesa para el Desarrollo de Tecnologías Asistivas Tokio Japón Organización Japonesa para el Desarrollo de Tecnologías Asistivas, Tokio. Japón.
Jacqueline CevallosPontificia Universidad Católica del Ecuador Quito Ecuador Pontificia Universidad Católica del Ecuador, Quito. Ecuador.
Jackeline PinosConsultora Organización Panamericana de la Salud Quito Ecuador Consultora Organización Panamericana de la Salud, Quito. Ecuador.
Francisco Pérez-TasigchanaCentro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC) Universidad UTE Quito Ecuador Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC). Universidad UTE, Quito. Ecuador.
Adrián DíazConsultor independiente Buenos Aires Argentina Consultor independiente. Buenos Aires. Argentina.
Alvaro WhittemburyFacultad de Ciencias de la Salud Universidad Internacional SEK Washington D.C. Estados Unidos Organización Panamericana de la Salud/Organización Mundial de la Salud, Washington D.C. Estados Unidos.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Ecuador, the health emergency caused by COVID-19 required the State's concerted effort to provide safe, effective, and free vaccines. At the start of 2022, the country reached broad vaccination coverage, placing it among the countries in the Americas with the strongest achievements in this area.To systematize and analyze the lessons learned from the introduction of the COVID-19 vaccine, the country and the Pan American Health Organization/World Health Organization (PAHO/WHO) implemented an intra-action review (IAR) during the application of the measures adopted, which presented the lessons learned and corrective measures to strengthen the deployment of vaccination.This article describes, based on the authors' experience and the results of the IAR, the introduction of vaccination in Ecuador, the timely response mechanisms, and the difficulties encountered in deploying vaccination in accordance with the national plan and in achieving the proposed objectives.

Indexed as

COVID-19 vaccinesEcuadorimmunization programsLatin Americavaccination coverage

Identifiers

PMID40786649
PMCPMC12330876

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.